Flow‐injection chemiluminescence of the luminol–potassium periodate system enhanced by TGA–capped CdTe quantum dots for the determination of theophylline
Abstract:The chemiluminescence (CL) behaviour of the luminol-potassium periodate system enhanced by CdTe quantum dots capped with thioglycolic acid (TGA-CdTe QDs) was studied using kinetic experiments, CL spectra, UV-vis absorption spectra and fluorescence spectra. The production of oxygen-containing reactant intermediates (O 2•− and OH • ) in the present CL system was verified by CL. The possible CL mechanism was discussed in detail. Furthermore, theophylline (THP) was determined based on its enhancement of the CL int… Show more
“…TGA-capped CdTe quantum dots (QDs) catalysed the luminol–KIO 4 CL system by generating radicals. 41 KIO 4 is stongly oxidizing and injected a hole into the valence band of CdTe QDs, producing O 2 ˙ − . The presence of a reducer, hydroxide ions (OH − ), injected an electron into the conduction band of CdTe QDs, producing ˙OH.…”
Section: Chemiluminescencementioning
confidence: 99%
“…TGA-capped CdTe quantum dots (QDs) catalysed the luminol-KIO 4 CL system by generating radicals. 41 KIO 4 is stongly oxidizing and injected a hole into the valence band of CdTe QDs, producing O 2…”
Different activation modes, including chemiluminescence, NIR, X-ray and ultrasound, have been employed to trigger specific light-mediated therapeutics, such as photodynamic therapy, photothermal therapy and drug delivery.
“…TGA-capped CdTe quantum dots (QDs) catalysed the luminol–KIO 4 CL system by generating radicals. 41 KIO 4 is stongly oxidizing and injected a hole into the valence band of CdTe QDs, producing O 2 ˙ − . The presence of a reducer, hydroxide ions (OH − ), injected an electron into the conduction band of CdTe QDs, producing ˙OH.…”
Section: Chemiluminescencementioning
confidence: 99%
“…TGA-capped CdTe quantum dots (QDs) catalysed the luminol-KIO 4 CL system by generating radicals. 41 KIO 4 is stongly oxidizing and injected a hole into the valence band of CdTe QDs, producing O 2…”
Different activation modes, including chemiluminescence, NIR, X-ray and ultrasound, have been employed to trigger specific light-mediated therapeutics, such as photodynamic therapy, photothermal therapy and drug delivery.
“…Colloidal quantum dots (QDs) such as CdTe have attracted much attention due to their unique characteristics, including nanoscale, wide absorption spectrum for short wavelengths, high PL quantum yield, excellent color purity, lower light scattering and size adjustable optical characteristics 8–12 . However, the development of CdTe QDs in solid‐state applications is hampered by their severe aggregation‐induced luminescence quenching.…”
Realizing efficient solid‐state luminescence is of great important to expand quantum dots (QDs) application fields. This work reports the preparation of CdTe@BaCO3 composite by a one‐pot precipitation method. Both steady‐state PL and PL decay characteristics in either solid‐state or colloid solution show no obvious difference, mainly benefited from the effective protection of BaCO3 on QDs from the external environment. By utilizing green and red CdTe QDs as dual‐color emission centers, precise emitting‐color control from green (0.312, 0.667) to red (0.691, 0.292) could be achieved in CdTe@BaCO3 composite by adjusting volume ratio of CdTe solution precursor. Our results demonstrate that this composite material shows bright solid‐state luminescence and facile adjustment of the emitting color in QDs‐based composite is feasible, which could offer new path to design color‐tunable luminescent materials for future optoelectronic applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.